Jaya Biosciences: Neuroscience Startup Chosen for SCbioDrive Accelerator Program

September 30, 2024

Jaya Biosciences was highlighted in a press release by SCbio for our work in developing CNS-directed gene therapies for neurodegenerative diseases like Alzheimer’s, Parkinson’s, and frontotemporal dementia as we begin the inaugural SCbioDrive Accelerator Program.

SCbio’s release details our focus on targeting upstream effector pathways and lysosomal dysfunction to address the potential root causes of these conditions, our precision medicine approach to targeting lysosomal gene mutations, our research suggesting that Alzheimer’s is likely a heterogeneous disease with distinct subpopulations, and more.

Read SCbio’s press release here: https://www.scbio.org/jaya-biosciences-neuroscience-startup-chosen-for-scbiodrive-accelerator-program/